MB

Michael Bonney

North America, Massachusetts, United States, Boston

Description

Mike Bonney was the Executive Chair of Kaleido's Board of Directors and served as CEO from June 2017 until August 2018. Previously, Bonney w...

Investor Profile

Michael Bonney has made 1 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Michael Bonney frequently co-invest with?

Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Michael Bonney?

Kaleido BioSciences

Bedford, Massachusetts, United States

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

Biotechnology
Series BSep 18, 2017
Amount Raised: $65,000,000